Research Paper Volume 9, Issue 3 pp 914—931
Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer
Figure 3. Overexpression ofRab1B and MMP9 proteins are associated with poor prognosis of CRC patients independent of clinical stage. (A) The overall survival (OS) and progression-free survival (PFS) of CRC patients with high or low Rab1B expression. P value was calculated by Log-rank test. (B) OS and PFS of patients with high or low MMP9 expression. (C) OS and PFS of stage I-II CRC patients with high or low Rab1B expression. (D) OS and PFS of stage III CRC patients with high or low Rab1B expression.